Immunogenicity of COVID ‐19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy
Summary: Immune responses to primary COVID‐19 vaccination were investigated in 58 patients with follicular lymphoma (FL) as part of the PETReA trial of frontline therapy (EudraCT 2016–004010‐10). COVID‐19 vaccines (BNT162b2 or ChAdOx1) were administered before, during or after cytoreductive treatmen...
मुख्य लेखकों: | Lim, YJ, Ward, V, Brown, A, Phillips, E, Kronsteiner, B, Malone, T, Jennings, D, Healy, S, Longet, S, James, T, Thomson, P, Farrell, L, Oates, M, Jackson, R, Morrison, A, Burns, M, Carroll, M, Klenerman, P, Turtle, L, Naisbitt, D, Rhodes, M, Robinson, K, Gatto, S, Young, M, Eyre, TA, Eyre, DW, Dunachie, S, Barnes, E |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
Wiley
2024
|
समान संसाधन
-
Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
द्वारा: Griffiths, R, और अन्य
प्रकाशित: (2010) -
Letter: Chemoimmunotherapy of adult acute leukaemia.
द्वारा: Peto, R, और अन्य
प्रकाशित: (1975) -
BNIP3 expression in follicular lymphoma.
द्वारा: Sington, J, और अन्य
प्रकाशित: (2007) -
A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy.
द्वारा: Robertson-Tessi, M, और अन्य
प्रकाशित: (2015) -
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
द्वारा: Eyre, T, और अन्य
प्रकाशित: (2017)